Search the Newsreel

INSP Price Today: Inspire Medical Systems, Inc. Stock Price, Quote & Chart | MEXC

Inspire Medical Systems (INSP) Stock May Be A Bargain On Raised 2026 Guidance

Inspire Medical Systems (INSP) has experienced a significant stock price decline over the past three years, yet current valuations suggest the shares are either fairly valued or undervalued. A Discounted Cash Flow (DCF) model estimates an intrinsic value of $56 per share, indicating the …

Why Are Inspire Medical Systems (INSP) Shares Soaring Today

Inspire Medical Systems (INSP) shares surged by 18.3% after the company reported better-than-expected quarterly results, raised its full-year guidance, and announced a new corporate restructuring initiative called Project Horizon. Oppenheimer upgraded the stock to Outperform with an $85 price target. This positive news follows …

Inspire Medical Systems (NYSE:INSP) Shares Gap Up on Earnings Beat

NSP Q2 Deep Dive: Margin Recovery Progress and Strategic HRScale Launch

NSP Q2 Deep Dive: Margin Recovery Progress and Strategic HRScale Launch HR outsourcing provider Insperity (NYSE:NSP) beat Wall Street's revenue expectations in Q2 CY2026, with sales up 1.7% year on year to $1.69 billion. Its non-GAAP profit of $0.34 per share was 6.9% above …

INSPIRE MEDICAL SYSTEMS INC : JP MORGAN RAISES TARGET PRICE TO $60 FROM $54

JP Morgan has increased its target price for Inspire Medical Systems Inc (INSP.N) to $60 from $54. This update reflects the analyst's revised outlook on the company's valuation. The article is a brief news alert from Reuters regarding this financial adjustment.

Inspire Medical Q2 Earnings Beat Estimates, '26 View Raised, Stock Up

Is Inspire Medical Systems (INSP) Fairly Valued After Q2 Beats And Raised Guidance?

5 Revealing Analyst Questions From Insperity’s Q2 Earnings Call

Inspire Medical Systems earnings beat by $0.38, revenue topped estimates

Inspire Medical Systems (NYSE: INSP) exceeded analyst expectations for its second-quarter earnings, reporting an EPS of $0.14 against an estimated $-0.24. The company also surpassed revenue estimates, bringing in $200.6 million compared to the consensus of $194.67 million. Looking ahead, Inspire Medical Systems projects …

Earnings call transcript: Inspire Medical beats Q2 2026 estimates, shares jump

Inspire Medical Systems (INSP) surpassed Q2 2026 revenue and adjusted EPS estimates, leading to a significant jump in shares despite a 7.6% year-over-year revenue decline due to coding and reimbursement issues. The company introduced "Project Horizon," a strategic growth plan to optimize operations and …

ETFs Investing in Insperity, Inc. Stocks

This article lists various ETFs that include Insperity, Inc. stocks in their holdings. It provides key details for each ETF, such as market value, weight of Insperity stock, issuer, management style, focus, expense ratio, assets under management (AUM), price, and 3-year NAV total return. …

Inspired Entertainment, Inc expected to post earnings of 4 cents a share - Earnings Preview

Inspired Entertainment, Inc is projected to report earnings of 4 cents per share. This information comes from a Refinitiv earnings preview. The full article content is behind a paywall on TradingView.

Inspire Medical Systems Q2 Adjusted Earnings, Revenue Fall; Raises 2026 Revenue Guidance

Inspire Medical Systems reported a decrease in Q2 adjusted earnings and revenue but exceeded FactSet estimates. The company posted adjusted EPS of $0.14 against an estimated $-0.24, and Q2 revenue of $200.6 million against an estimated $194.7 million. Despite the fall in adjusted earnings …

Inspire Medical Systems, Inc. Announces Second Quarter 2026 Financial Results, Raised 2026 Guidance, and Strategic Growth Plan

Inspire Medical Systems announced its second-quarter 2026 financial results, reporting revenue of $200.6 million and diluted EPS of $0.01. The company raised its full-year 2026 revenue guidance to $835 million to $875 million and introduced "Project Horizon," a strategic growth plan designed to generate …

Inspire Medical Q2 revenue falls to $200.6 million as guidance raised

Inspire Medical (INSP) reported second-quarter 2026 revenue of $200.6 million, a 7.6% decrease year-over-year, with net earnings of $0.3 million. Despite the revenue fall, the company raised its full-year 2026 revenue outlook to $835 million to $875 million and announced "Project Horizon," a strategic …

Compared to Estimates, Inspire (INSP) Q2 Earnings: A Look at Key Metrics

Inspire Medical Systems (NYSE:INSP) Issues Earnings Results, Beats Expectations By $0.38 EPS

Inspire Medical Systems (INSP) Q2 Earnings and Revenues Beat Estimates

Inspire Medical Systems (NYSE:INSP) Reports Bullish Q2 CY2026, Stock Jumps 13.6%

Inspur Digital Enterprise Technology Sees 1H Rev CNY3.7B-CNY3.8B >0596.HK

What To Expect From Inspire Medical Systems’s (INSP) Q2 Earnings

Inspire Medical Systems (INSP) is scheduled to announce its Q2 earnings this Monday after the bell. Analysts expect a 10.3% year-on-year revenue decline, despite the company's history of exceeding expectations. Its peers, Bausch + Lomb and Baxter, recently reported stronger-than-anticipated Q2 results.

Inspur Digital Warns of Sharply Lower Interim Profit as AI Strategy Reshapes Business Mix

Inspur Digital Enterprise Technology Limited Provides Unaudited Consolidated Earnings Guidance for the Six Months Ended 30 June 2026

Insperity (NSP) Rebounds On Earnings And Guidance But Is The Stock Fully Valued

Insperity (NSP) recently reported strong Q2 2026 earnings, showcasing sales growth, profitability, and new capital actions. Despite a significant share price rebound this year, the stock trades above the average analyst target. While some valuations suggest it's overvalued at $50.61, a Discounted Cash Flow …

NSPR|InspireMD Inc|Price:0.654|Chg%:-0.018

This article provides a comprehensive stock analysis of InspireMD Inc (NSPR) by TradingKey, assigning it a "relatively very healthy" fundamental score and high growth potential, though its valuation is deemed "fairly valued." Key insights include high institutional ownership, multiple "Buy" ratings from analysts with …

Insperity Inc (NSP) Stock Down 6.3% -- Now Undervalued? GF Score: 68/100

Insperity Inc (NSP) saw its stock fall by 6.3% to $50.61, despite a strong year-to-date performance. GuruFocus assesses the stock as 44.4% undervalued compared to its GF Value™ of $91.05, but cautions that its current unprofitability and negative cash flow suggest a potential value …

InspireMD Eliminates Chief Commercial Officer Position

InspireMD has eliminated the position of Chief Commercial Officer, effective July 31, 2026, with Shane Gleason's employment ending on that date. This change signals a potential shift in the company's commercial strategy or organizational priorities. While the most recent analyst rating is a Buy …

Vanguard Portfolio Management (INSP) discloses 2.13M-share, 7.37% stake in Inspire

Vanguard Portfolio Management LLC has disclosed an amended 7.37% beneficial ownership stake in Inspire Medical Systems Inc., totaling 2,126,116 shares. The filing indicates Vanguard has sole voting power over 37,155 shares and sole dispositive power over all 2,126,116 shares, held across various Vanguard funds …

How Insperity Is Adapting to AI and a Rapidly Changing PEO Market

Insperity (NSP) is working to regain growth momentum by adapting to the evolving Professional Employer Organization (PEO) market, which is experiencing significant growth. The company is focusing on its HRScale platform, a partnership with Workday, and AI initiatives to convert demand for outsourced HR …

Insperity Stock Gains 3% Since Reporting Q2 Earnings Beat: Here's Why

Insperity (NSP) reported strong second-quarter 2026 results, with earnings and revenues surpassing Zacks Consensus Estimates, leading to a 2.7% stock gain. The company's adjusted earnings per share rose 31% year-over-year, and revenues increased by 2%, driven by lower operating expenses and margin recovery initiatives. …

Insperity (NSP) Stock Trades Down, Here Is Why

Insperity (NSP) Stock Trades Down, Here Is Why What Happened? Shares of HR outsourcing provider Insperity (NYSE:NSP) fell 7.3% in the afternoon session after its second-quarter results and full-year guidance raised concerns about underlying business weakness. While adjusted earnings per share beat the company's …

Insperity (NSP) Stock Catches Relief As Margin Recovery Starts Taking Hold

Insperity (NSP) stock has seen a 1.6% increase, providing some relief to investors after a volatile year. This improvement is attributed to an easing of profit pressure, with Q2 2026 adjusted EPS and EBITDA exceeding company midpoints. While the company is still loss-making on …

InspireMD appoints Kathleen Kennedy as SVP of global sales By Investing.com

InspireMD, Inc. has appointed Kathleen Kennedy as Senior Vice President of Global Sales and Marketing. Kennedy, who previously served as Sales Director for InspireMD, brings over 30 years of medical device sales leadership experience and will report to CEO Marvin Slosman. Her appointment aligns …

InspireMD Inc.: InspireMD Appoints Carotid Intervention Commercial Leader Kathleen Kennedy as Senior Vice President of Global Sales and Marketing

InspireMD, Inc. has announced the appointment of Kathleen Kennedy as Senior Vice President of Global Sales and Marketing. Kennedy, with over 30 years of medical device sales leadership experience, including in carotid intervention, will report to CEO Marvin Slosman. Her role will be crucial …

Insperity, Inc. Revenue Breakdown – NYSE:NSP

Insperity, Inc. (NYSE: NSP) generated $6.81 billion USD in revenue last year, primarily from its Human Resources and Business Solutions segment, which also accounted for the majority of revenue at $6.81 billion USD. All of the company's revenue came from the United States, showing …